Category Archives: Health Reform

Unconstitutional Retaliation by Health Agency (NYSDOH) Cost Taxpayers $25 Million

The New York State Department of Health (NYSDOH) agreed to pay the owners of the Beechwood Nursing Home, located in Rochester, New York, $25 Million dollars to settle litigation in which a federal jury had already determined that NYSDOH officials, in a context of malfeasant comportment, had illegally revoked the operating license of the facility in 1999 in retaliation against its owners, resulting in Beechwood’s closure. The jury was scheduled to decide how much to award in damages when the parties reached a settlement.

The NYSDOH, known for disregarding Fourteenth Amendment rights (such as the right to have witnesses for one’s defense) in its actions against the state’s health professionals, has been challenged to conform to proper judicial practices, most notably via bills introduced by the New York State Legislature. All bills were vetoed by Governor George E. Pataki in 2004. According to Dr. Gérard Sunnen, a New York psychiatrist with long experience caring for patients in city hospitals and nursing homes, “the closure of the Home undoubtedly tore apart the social fabric and the connective support sustaining its tenants and patients, likely resulting in serious stress reactions, with all attendant consequences, physical and psychological.”

The Rochester Democrat and Chronicle filed this report on the unconstitutional retaliation settlement. According to its August 22, 2012 article, the presentation of provocative e-mails, written by NYSDOH officials in the wake of Beechwood’s closure, was a key point in the case. Jurors in the case “pointed to the e-mails as the proof they needed of the state’s malice.” Although Beechwood’s owners sued multiple NYSDOH officials at the outset of the litigation in 2002, five were eventually found liable for the illegal revocation of the operating license: current Health Department officials Susan Baker and Cynthia Francis, and former officials Laura Leeds, Sanford Rubin, and Sharon Carlo. These individuals will not be personally liable for the $25 Million settlement.

New York State taxpayers, however, are the ones to shoulder the burden of the full award.

Via EPR Network
More Healthcare press releases

Will the Catholic Church & the U.S. Courts Embrace Advanced Cell Technologies “Embryo-Safe” Technique Using Embryonic Stem Cells?

Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.
• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Via EPR Network
More Healthcare press releases

Side by side comparison of Advanced Cell Technology & Geron Corporation

Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements: http://www.sec.gov/Archives/edgar/data/11...

Via EPR Network
More Healthcare press releases

New Website Dedicated To Stem Cell Investors

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Via EPR Network
More Healthcare press releases

Housing Market Crash and Rising Medical Costs, Is There A Connection?

As millions of American homeowners know, the housing market crash was fueled by inflated home values and bank loans that were high above the equity or actual value of “underwater” homes. According to Trisha Lotzer, JD., health-care attorney and CEO of Physis, Inc., a similar threat for banks, borrowers and owners of many of the nation’s medical, dental, optometry and veterinary practices must be averted.

Like residential real estate, medical practices may be marketed and sold by brokers. Brokers in the business of selling medical practices commonly charge 7-12% commission. The commission alone can add $80,000 to $2,000,000 to the purchase price, depending on the size of the facility–and drive up the bank note accordingly.

Like real estate agents, the job of the practice broker is to get the seller the highest selling price possible. Unlike real estate agents, however, brokers are often the only ones who value the practices they have for sale–giving them a built in incentive to inflate the value of practices and increase their commission. Ross Landreth, MBA, explains that the problem occurs when a practice is arbitrarily valued, purchased and financed at $1,500,000, but only has an actual fair market value (per USPAP approved valuation standards) of $850,000. This could mean that the practice does not cash-flow at $1,500,00 and that the new purchasers would have to raise the price of services in order to maintain profitability and pay back the bank note. This increase in the cost of health care does not increase the earnings of the practice owners or physicians but is passed along to patients and insurance providers.

Via EPR Network
More Healthcare press releases

How to Combine Medicare Part B with Medicare Part D

HealthInsuranceFinders.com News and Information Center today covered the topic “Not everybody on Medicare has the same coverage”. In fact the goal of the Medicare reforms that have been enacted over the past decade or so have been to give seniors more options. Many believe these changes in the system have tended to over complicate things. On the other hand, the large variety of Medicare plans, and Medicare Supplement plans now available, ensure that seniors are only paying for the coverage they want and need.

Among your options with original Medicare and Medicare Supplement Insurance are Medicare Part B and Medicare Part D. Medicare Part B and D can be combined to give you very comprehensive coverage for medications.

Medicare Part B is your “out patient” medical coverage, in other words, it pays for doctors visits, home healthcare to a degree, durable medical equipment and some forms of medications. Things that are technically medication that could be covered under your Part B benefit include, vaccines, flu shots, allergy injections, Immunosuppressant drugs and some oral cancer treatments. For the most part however, Part B is not designed to pay for regularly taken prescription medication. That is where Part D comes in.

Even if you have one of the lettered Medicare Supplemental Health Insurance plans (with the exception of some of the older plans issued before 2002 which are no longer sold) – you still will require Medicare Part D to receive a prescription drug benefit from Medicare.

Medicare Part D will cover all of the following medications:

* Any approved doctor prescribed medication taken regularly for a chronic condition.
* Any approved doctor prescribed medication for a short-term condition.
* Inhaled nebulizers.
* Vaccines, even those that are not prescribed as a result of injury.
* Hepatitis B vaccines.
* Oral anticancer drugs that may have been prescribed for reasons other then cancer treatment.
* And many more types of medication.

Independent health insurance companies sell Medicare Part D Prescription Drug plans. What drugs they cover and how much they pay for medications does vary depending on the type of Part D plan selected. If you are soon to enroll in Medicare, or are currently enrolled and your prescription drug needs are changing – discuss all of your medications with a Medicare Supplemental Insurance specialist, he or she will help you find the right combination of Medicare and Medicare Supplemental insurance that will work best for you.

Via EPR Network
More Healthcare press releases

HealthInsuranceFinders.com Releases Comprehensive Guide

HealthInsuranceFinders.com, an insurance quote aggregator offering the public the option of comparison shopping in the health insurance field, offers users access to its new guide designed to offer insightful information on health insurance for individuals.

Before you purchase an individual health insurance policy, take a look athealthinsurancefinders.com and their new insurance guide. It could save you time, money, or both.

Dedicated to educating Americans looking for medical coverage, their new individual health insurance guide is full of up-to-date informationregarding today’s coverage, your options, and how the new healthcare bill will impact individuals who don’t get medical insurance from an employer.

It also addresses more traditional concerns, including managing maternity issues, understanding how prices and premiums are decided, and the best means of finding good quality coverage at affordable prices.

No stranger to the ever-changing health insurance industry, healthinsurancefinders.com offers a variety of consumer resources on a state and federal level, including information for the unemployed, health insurance answers geared towards common but frustrating Medicare questions, and even information designed to explain COBRA and to examine supplemental insurance considerations.

“Health insurance is a hot topic today”, says Grace Della, VP of online marketing, “But with so much conflicting information out there, it’s easy to get overloaded. We like to keep our guides clear and easy to read, so consumers can focus on what’s really important: getting the coverage they need”.

Via EPR Network
More Healthcare press releases

The Impact of Health Reform Industry

The HealthInsuranceFinders.com News Center reported that under the rules and stipulations outlined in the new health reform law, the U.S. Department of Health and Human Services (HHS) will be tasked with not only revamping current health coverage policies and procedures, but also restricting costs for health plans and ensuring that health insurance for individuals as well as for families is easily attainable. As our lawmakers begin this overwhelming task of streamlining health plans, it is critical for them to keep in mind the overall impact their actions will have on the health industry, children and e-health and patient care.

Health Reform Industry Impact

With all the changes and red tape surrounding the new laws, one might wonder if the pharmaceutical and medical technology industries will be affected during the transition. In the early 90’s, the pharmaceutical industry displayed some stiff resistance to restructuring and reforming America’s health plans and health insurance for individuals. However, in modern times, the sector has embraced and even encouraged the widespread reshaping of health coverage in this country. While motivating these changes, the industry also exercised a little self-preservation by outlining the terms of a deal for protection during the reform.

The medical technologies sector will experience a hybrid of new opportunities as well as never before experienced difficulties throughout the revamping of the current policies. In order for future medical progress to remain current and relevant, new payment methods and procedures must be implemented to streamline the process.

Children and Insurance Coverage

Results from recent studies really solidify the need for policy restructuring in an effort to best protect minors through Children’s Health Insurance Program (CHIP) and Medicaid. These efforts must be in place as soon as possible to ensure a more seamless transition as we prepare to extend health insurance to individuals that have previously been uninsured.

Children currently covered under a private policy will often lose benefits within 90 days of a parent losing a job. This number is 6.5% higher than children who have parents that continue to stay employed. To eliminate this dilemma, Gerry L. Fairbrother of the Cincinnati Children’s Hospital Medical Center, maintains local and federal officials need to eliminate waiting periods and eligibility restrictions to these children when their parents lose their jobs.

Also, despite being eligible for Medicaid or CHIP, approximately two million children enrolled in these programs still lost coverage in 2008. Benjamin D. Sommers of Harvard University noted this trend in his analysis spanning 2002 through 2008. He also made note that while retention rates for children in publicly offered plans have gone up, new matriculation has gone down.

Via EPR Network
More Healthcare press releases

FDA Blunder and Cover-up Kills Millions

The World Health Organization (WHO) has just recommended that drinking water contain 25-50 mg of magnesium (Mg) per liter to prevent deaths from heart attack and stroke. MgWater.com/download American bottled water averages <5 mg of magnesium per liter, while bottled water in the rest of the world averages about 20 mg of magnesium per liter.

FDA Blunder and Cover-up Kills Millions

The FDA and DOJ caused the Mg-deficient-water problem by destroying the American mineral water industry in the 1930’s, in the mistaken belief that pure water was good, and that mineral water was just impure water.

Epidemiological studies indicate that millions of Americans have died due to the FDA’s and DOJ’s destruction of the American mineral water industry. See:
http://www.mgwater.com/anderson.shtml
http://www.mgwater.com/lancet.shtml
http://www.mgwater.com/finland.shtml
http://www.mgwater.com/singh.shtml

For decades, the evidence has been overwhelming that Americans are very deficient in Mg, as evidenced by the 23% shortfall from the RDI, yet the FDA and DOJ have covered up their blunder, getting a Federal lawsuit dismissed before the evidence could be shown, and keeping silent about the millions of deaths indicated by over 50 epidemiological studies from nine countries.

Now, it is up to the FDA and DOJ to end this travesty, requiring the Mg content of bottled or canned beverages to be put in labels’ nutrition panels, and requiring that all bottled or canned beverages contain at least 25 mg of Mg per liter.

Foods no longer contain as much magnesium as they did a century ago, due to increased food processing and possible soil depletion. Consumers have generally rejected magnesium-rich whole grain foods like brown rice and brown bread, in favor of magnesium-stripped white rice and white bread. Bottled beverages are the most practical way of delivering magnesium to consumers.

Recent studies clearly confirm that water-borne Mg is far, far better in preventing cardiovascular pathologies than food-borne Mg. For more information, go to the Magnesium Online Library at www.MgWater.com.

Via EPR Network
More Healthcare press releases

Physician Offers Own Brand Of Affordable Insurance Alternative

Cedar Park family medicine physician Melissa J. Urrea, M.D. believes taking care of your health shouldn’t be a difficult financial decision. And while the recently-signed Health Care Bill mandates that all individuals will be required to obtain health insurance by 2014, that still leaves several years of challenging options on how to best obtain quality medical care. That’s why she recently introduced through her practice, Trinity Family Medicine, a pre-paid package of medical services. Trinity HealthSpan ™ provides access to comprehensive health care to uninsured and underinsured individuals and families.

Nearly one in four Central Texas residents currently lives with inadequate or no health insurance — and that statistic is expected to rise as a result of the recession. Dr. Urrea’s plan helps to  bridge the gap between the need for and access to quality health care services.

For an annual fee of less than $800, Trinity HealthSpan ™ provides:

  • An annual examination (including prostate screening)
  • Lab work (including a complete metabolic panel, diabetes screening, kidney and liver function screening, electrolyte evaluation, complete blood count, anemia evaluation, thyroid function evaluation, cholesterol and lipid panel, urinalysis, urine protein evaluation)
  • Electrocardiogram (EKG)
  • Tetanus vaccination
  • Influenza vaccination
  • Three routine office visits (including follow up for a particular disease/condition and sick visits)
  • Access to coordinated services (such as labs) at reduced rates

The concept for Trinity HealthSpan ™ originated when Dr. Urrea was challenged with managing the care of chronically ill individuals who had no or limited insurance or were self-employed. “For someone with a condition like diabetes, allergies or asthma, it is imperative to focus not only on disease management, but overall wellness,” said Dr. Urrea. “That involves multiple visits to a physician, along with moderate diagnostic testing to monitor the condition.”

As the recession affected more and more of her patients, Dr. Urrea consulted with her practice’s business manager to determine how they could assist their patients in maintaining regular access to care. The practice reached out to ancillary service providers like laboratories and negotiated reduced rates on behalf of patients who purchase the Trinity HealthSpan ™ package. Trinity HealthSpan ™ also connects patients with pharmacies offering low-cost, generic prescription plans. Local retailers like HEB and Target offer plans that provide medications for as little as $5 a month, which is actually less money than most insurance plan co-pays.

For an uninsured individual not participating in Trinity HealthSpan ™ , the cost of the pre-paid package of services would be $1,050. Similarly, if an insured patient paid an average of $400 per month (not including deductibles and co-pays) in insurance premiums, they could save more than $4,000 annually by enrolling in Trinity HealthSpan ™ . “Even if the patient needed X-rays or an MRI, it would still be less expensive than through their insurance plan,” said Dr. Urrea.

“As a physician and patient, I wanted to bring peace of mind to those individuals and families who can’t afford insurance but deserve state-of-the-art medical services,” added Dr. Urrea. Patients may also purchase “a la carte” customized care packages with fewer services or those related to a specific health condition. Plan financing options are also available.

Trinity Family Medicine provides care for the entire family, including pediatrics, women’s health, men’s health, general medicine, herbal medicine, sleep studies, and cosmetic medicine. House calls are also an option for established patients depending on location.

Dr. Urrea is a graduate of the University of Texas Medical Branch at Galveston (UTMB). She is board-certified by the American Board of Family Medicine, a member of the American Academy of Family Physicians, and serves as an associate clinical professor in the Department of Family Medicine at the University of Texas Medical Branch at Galveston.

For more information or to sign up for Trinity HealthSpan ™, call Trinity Family Medicine at 512-258-1645 or visit www.urreamd.com.

Via EPR Network
More
Healthcare press releases

Nursing Shortfall In The UK, According To Hays, Specialist Recruitment

According to Hays, specialist recruitment, the acute shortage of qualified workers, which continues to plague the nursing sector, is particularly apparent for A&E, critical care (ITU), theatre, intensive care (ICU) and emergency medicine nurses.

hays.com healthcare

The magnitude of the shortage has however now also spilt over into other areas of nursing jobs such as obstetrician, orthopaedic, anaesthetic and gynaecologist nurses are also highly sought after by the health service. Additionally there is currently a shortage of accident and emergency expertise and a growing requirement for nurses from an emergency medicine background.

“Without a doubt, there is a shortage of nurses in the UK. The available talent from abroad throws an important lifeline given the pressing need for skilled nurses. Around 10% of nurses working in the UK have trained abroad and it is important that skills shortages in the healthcare sector continue to be addressed where possible, using labour from overseas where necessary,” added Simon Hudson, the new Director of Hays Global Resourcing.

The UK has been able to benefit from the global mobility of the nursing sector and tap into the worldwide nursing talent pool to fill its vacancies, however, “The shortage of nurses is not just limited to the UK. Demand exceeds supply across the world, which in turn fuels this cyclical international movement of labour in the nursing profession,” continued Simon.

Many UK nurses are leaving to go and work abroad to destinations such as Canada, Australia, the Middle East and the United States. There are several reasons why nurses from the UK are attracted to overseas destinations, but clearly it is more a case of lifestyle and financial reasons rather than an inability to find a job in the UK.

Nursing in the UK not only offers excellent and varied opportunities to learn valuable skills but also enables individuals to make a positive difference to the lives of others. The NHS encourages applications from people with a wide range of academic and vocational qualifications.

“Going on a work placement or volunteering are excellent routes into the nursing sector and a great way to get a feel for the industry,” said John Faraguna, the newly appointed Managing Director of Hays Health and Social Care. Other ways of entering the industry include cadet schemes and apprenticeships, especially for those with previous NHS experience, for example, clinical support workers and healthcare assistants.

According to recent statistics from the Royal College of Nursing (RCN), one in three community nurses are over 50 and over a fifth of practice nurses are over 55, which adds up to around 200,000 nurses who are due to retire over the next decade.

This represents almost 50% of the worker population and this will leave a massive skills shortfall if these problems are not addressed. This is a worrying prospect at a time when the size of the UK’s elderly population looks set to continue to increase over the coming years, meaning the demand for specialist nurses will continue to grow with it.

“The best solution to this issue is a combination of more effective utilisation and retention of skilled nurses, increased emphasis on training new nurses and, in the short term, increased international recruitment” concluded John,

 

About Hays Healthcare:
Hays Healthcare is part of Hays plc, the leading global specialist recruitment group. It is market leader in the UK and Australia, and one of the market leaders in Continental Europe. As at 30 June 2008, the Group employed 8,294 staff operating from 380 offices in 28 countries across 17 specialisms.

For the year ended 30 June 2008:
– the Group had revenues of £2.5 billion, net fees of £786.8 million and operating profit before exceptional items of £253.8 million; 
– the Group placed around 80,000 candidates into permanent jobs and around 300,000 people into temporary assignments; 
– the temporary placement business represented 49% of net fees and the permanent placement business represented 51% of net fees. 

Via EPR Network
More 
Healthcare press releases

Glaucoma is the leading cause of preventable blindness worldwide. 60 million Americans are at RISK for developing Glaucoma

Dr. Lynnette Williams-Young, S.A.V.E Program Coordinator, in conjunction with National Glaucoma Awareness with support from Park Avenue Laser Vision, Dr. Emil Chynn and Roman Iospa, CEO of BiCOM Inc., home of Glaucoma Eye Test, are providing free Glaucoma screening events for the whole community.

Prevent Blindness America Survey found that:

  • Blindness ranked third (after cancer and heart disease) as people’s major fear.
  • It is estimated that over 4 million Americans have glaucoma but only half of those know they have it.
  • Glaucoma is 6 to 8 times more common in African-Americans than Caucasians.
  • Everyone is at risk for glaucoma from babies to senior citizens. Yes, older people are at a higher risk for glaucoma but babies can be born with glaucoma (approximately 1 out of every 10,000 babies born in the United States).

National Glaucoma Awareness Month presents an opportunity to educate and screen those most at risk for developing the “sneak thief of sight”. Dr.Williams-Young is the coordinator for the S.A.V.E program.

The “Sight for A Vision Exchange” is a program inspired by Sis. Mae McGill and Bishop James Gaylord and developed by Dr. Chynn and Dr. Williams-Young to raise $50,000 to benefit the Capital Stewardship Campaign of Kelly Temple Church.

Through the partnership between Park Avenue Laser Vision Center and Kelly Temple, we will be able to provide quality affordable laser vision correction for church members. Also, we will be able to provide education about laser vision correction and educate about maintaining a lifetime of good ocular health. Ultimately, this will reduce the fear of laser vision correction in the African American community.

Glaucoma screenings will be performed with BiCOM’s non-invasive, through the eyelid Tonometer Diaton (www.GlaucomaEyeTest.com) – the newest, safest way to screen for high intraocular pressure (IOP), which can be an indication of Glaucoma.

Join us for a free eye pressure screenings at Park Avenue Laser Vision 102 East 25th Street (& Park Avenue South). Call Park Avenue Laser Vision with any questions and directions at 212-741-8628.

About “Sight For A Vision Exchange” (S.A.V.E) – The objective of S.A.V.E is to provide affordable laser vision correction for church members, provide education about laser vision correction and reduce fear of laser vision correction in the African-American community.

About Park Avenue Laser Vision – New York’s Only No-Flap, All-Laser Vision Correction. http://www.ParkAvenueLaser.com

About BiCOM Inc. – BiCOM Inc. home of Tonometer Diaton a.k.a “Glaucoma Eye Test” allows to safely screen for intraocular pressure through the eyelid. BiCOM Inc. is a continued supporter of Glaucoma screening / educational programs nationally and internationally. More: http://www.TonometerDiaton.com

Via EPR Network
More
Healthcare press releases